New hope for rare disease patients: study tests three rescue treatments for stubborn vasculitis
NCT ID NCT04871191
First seen Apr 03, 2026 · Last updated May 20, 2026 · Updated 2 times
Summary
This study is for people with granulomatosis with polyangiitis, a rare disease where blood vessels get inflamed, who haven't improved with usual treatments. It compares three different drug combinations to see which works best to control the disease. About 42 adults will take part, and the goal is to reduce symptoms and prevent flare-ups, though ongoing medication is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital de la Croix Saint Simon
RECRUITINGParis, 75020, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.